Full name
SPES BP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,1 | 0,3 | 110,7 |
Gross profit (loss) | 0,6 | 0,1 | 0,3 | 254,2 |
EBITDA | 0,7 | 0,1 | 0,4 | 176 |
Short time liabilities | 1 | 2,2 | 2,9 | 32,9 |
Other operating costs | 0 | 0 | 0 | -7 |
Equity capital | 1,4 | 1,5 | 1,7 | 13,9 |
Operating profit (EBIT) | 0,6 | 0,1 | 0,3 | 138,3 |
Assets | 3,3 | 4 | 4,8 | 19,6 |
Net profit (loss) | 0,5 | 0,1 | 0,2 | 251,3 |
Cash | 0,3 | 0,4 | 0,2 | -39,5 |
Net income from sale | 14,4 | 16,1 | 17,4 | 7,8 |
Liabilities and provisions for liabilities | 1,8 | 2,5 | 3,1 | 23 |
Working assets | 1,8 | 2 | 2,2 | 12,3 |
Other income costs | 0,2 | 0 | 0 | -∞ |
Depreciation | 0 | 0 | 0,1 | 380,7 |
% | % | % | p.p. | |
Profitability of capital | 37,2 | 4 | 12,2 | 8,2 |
Equity capital to total assets | 43,9 | 37 | 35,2 | -1,8 |
Gross profit margin | 4,2 | 0,5 | 1,5 | 1 |
EBITDA Margin | 4,6 | 0,9 | 2,4 | 1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 50 | 62 | 12 |
Current financial liquidity indicator | 1.7231889963150024 | 0.8880360126495361 | 0.7504531741142273 | -0,1 |
Net dept to EBITDA | 0.6268861293792725 | -0.2880070209503174 | 0.055503640323877335 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane